DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme Life Science Investing
Q BioMed Announces Licensing Agreement for Development of Drug to Treat Rare Pediatric Disorder Biotech Investing
